Rare disease diagnosis programme unveiled by Takeda
An Indian company, part of a broader group of firms under the Takeda, banner has announced a new diagnostics programme aimed towards rare diseases. The “ILLUMINATE” programme, independently run and managed by PerkinElmer and sponsored by Baxalta Bioscience India, aims to improve diagnosis rates of patients with Lysosomal Storage Disorders (LSD). Raredisease.org defines LSDs …
Rare disease diagnosis programme unveiled by Takeda Read More »
